<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>InSpiro &#187; Ivalina_Pavlova</title>
	<atom:link href="http://inspiro-bg.com/author/ivalina_pavlova/feed/" rel="self" type="application/rss+xml" />
	<link>http://inspiro-bg.com</link>
	<description>Списание за респираторна медицина и вдъхновение</description>
	<lastBuildDate>Tue, 27 Oct 2026 09:13:05 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Нови данни от Boehringer Ingelheim подкрепят потенциалната употреба на nintedanib при деца и юноши с фиброзираща интерстициална белодробна болест</title>
		<link>http://inspiro-bg.com/novi-danni-ot-boehringer-ingelheim-podkrepyat-potentsialnata-upotreba-na-nintedanib-pri-detsa-i-yunoshi-s-fibrozirashta-interstitsialna-belodrobna-bolest/</link>
		<comments>http://inspiro-bg.com/novi-danni-ot-boehringer-ingelheim-podkrepyat-potentsialnata-upotreba-na-nintedanib-pri-detsa-i-yunoshi-s-fibrozirashta-interstitsialna-belodrobna-bolest/#comments</comments>
		<pubDate>Tue, 31 Jan 2023 09:42:09 +0000</pubDate>
		<dc:creator>Ivalina_Pavlova</dc:creator>
				<category><![CDATA[2022]]></category>
		<category><![CDATA[Акцент на началната страница]]></category>
		<category><![CDATA[Архив]]></category>
		<category><![CDATA[Брой № 4 (67) / септември 2022]]></category>
		<category><![CDATA[Лечебница]]></category>
		<category><![CDATA[Рубрики]]></category>

		<guid isPermaLink="false">http://inspiro-bg.com/?p=16605</guid>
		<description><![CDATA[<a href="http://inspiro-bg.com/wp-login.php">Влезте</a> или <a href="http://inspiro-bg.com/wp-login.php?action=register">се регистрирайте безплатно</a>, за да получите достъп до пълното съдържание и статиите на списанието в PDF формат.]]></description>
		<wfw:commentRss>http://inspiro-bg.com/novi-danni-ot-boehringer-ingelheim-podkrepyat-potentsialnata-upotreba-na-nintedanib-pri-detsa-i-yunoshi-s-fibrozirashta-interstitsialna-belodrobna-bolest/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
